DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol

DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol

<p><strong>Objective:</strong> The main purpose of this study is to evaluate the potential clinical impact of pharmacogenetic testing on the reduction of the toxicity in patients treated with fluoropyrimidines. This will be achieved by comparing the frequency of adverse events...

Full description

Bibliographic Details
Main Authors: Ana Hernández-Guío, M.ª Ángeles Bernabéu-Martínez, Andrés Corno-Caparrós, M.ª Teresa Aznar-Saliente, Manuel Bonete-Sánchez, Miguel Ángel Calleja-Hernández
Format: Article
Language:English
Published: Grupo Aula Médica 2021-05-01
Series:Farmacia Hospitalaria
Subjects:
clinical protocols
precision medicine
fluoropyrimidines
pharmacogenetics
toxicity
genetic polymorphism
dpyd
dihydropyrimidine dehydrogenase
Online Access:http://www.aulamedica.es/fh/pdf/11607.pdf

Internet

http://www.aulamedica.es/fh/pdf/11607.pdf

Similar Items